Literature DB >> 15012859

Monotherapy versus multi-drug therapy for the treatment of perforated appendicitis in children.

Evan P Nadler1, Kimberly K Reblock, Henri R Ford, Barbara A Gaines.   

Abstract

BACKGROUND: Children with perforated appendicitis often have a prolonged hospital course complicated by surgical site or intra-abdominal infections. Treatment with multiple intravenous (IV) antibiotics after appendectomy has been the standard of care for these patients. We have recently adopted a protocol using piperacillin-tazobactam (PT) as a single agent in lieu of the standard multi-drug regimen (MD). We hypothesized that PT would be as effective as MD in reducing postoperative complications and would result in decreased resource utilization.
METHODS: We reviewed the medical records of all children admitted to our hospital between January 1, 1998 and December 31, 2001 with the diagnosis of perforated appendicitis. Patients who underwent operation within the first 24 h of admission were divided into two groups based on their antibiotic regimen: PT versus MD. Demographic data, duration of presenting symptoms, initial WBC, length of stay, and infectious complications were abstracted. Categorical data were compared using Chi square analysis; continuous variables were compared using Student's t-test when the data were normally distributed and the Mann-Whitney U test when the data were skewed.
RESULTS: There was no difference between the PT (n = 51) and MD (n = 43) groups with respect to age, duration of presenting symptoms, initial WBC, or length of hospital stay. However, patients in the MD group had a significantly higher overall complication rate than those in the PT group (14/43 vs. 4/51, p = 0.002). Antibiotic-related complications including surgical site infections, venous catheter-related infections, intra-abdominal abscesses, and drug reactions were also higher in the MD group (10/43 vs. 4/51, p = 0.04). The outpatient charges for each patient based on an average of seven days of home antibiotics were $2,460 for the PT group and $4,349 for the MD group.
CONCLUSIONS: Children with perforated appendicitis can be managed effectively with a single broad-spectrum antibiotic after appendectomy. Monotherapy is not only more efficacious than multi-drug therapy, but may be more cost effective. The use of monotherapy for children with perforated appendicitis after adequate source control should be considered the treatment of choice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15012859     DOI: 10.1089/109629603322761382

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  8 in total

Review 1.  Complicated Intra-Abdominal Infections: The Old Antimicrobials and the New Players.

Authors:  Young R Lee; Danni McMahan; Catherine McCall; Gregory K Perry
Journal:  Drugs       Date:  2015-12       Impact factor: 9.546

Review 2.  Management of complicated acute appendicitis in children: Still an existing controversy.

Authors:  Nick Zavras; George Vaos
Journal:  World J Gastrointest Surg       Date:  2020-04-27

3.  Once Daily Dosing of Ceftriaxone and Metronidazole in Children With Perforated Appendicitis.

Authors:  Ji Yeon Lee; Saudia Ally; Brian Kelly; David Kays; Lisa Thames
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Mar-Apr

4.  Evidence-based adjustment of antibiotic in pediatric complicated appendicitis in the era of antibiotic resistance.

Authors:  Kin Wai Edwin Chan; Kim Hung Lee; Jennifer Wai Cheung Mou; Sing Tak Cheung; Jennifer Dart Yin Sihoe; Yuk Him Tam
Journal:  Pediatr Surg Int       Date:  2010-02       Impact factor: 1.827

5.  Morbidity of peripherally inserted central catheters in pediatric complicated appendicitis.

Authors:  Jason P Sulkowski; Lindsey Asti; Jennifer N Cooper; Brian D Kenney; Mehul V Raval; Shawn J Rangel; Katherine J Deans; Peter C Minneci
Journal:  J Surg Res       Date:  2014-03-13       Impact factor: 2.192

6.  Single daily dosing ceftriaxone and metronidazole vs standard triple antibiotic regimen for perforated appendicitis in children: a prospective randomized trial.

Authors:  Shawn D St Peter; Kuojen Tsao; Troy L Spilde; George W Holcomb; Susan W Sharp; J Patrick Murphy; Charles L Snyder; Ronald J Sharp; Walter S Andrews; Daniel J Ostlie
Journal:  J Pediatr Surg       Date:  2008-06       Impact factor: 2.545

7.  The microbiology of bacterial peritonitis due to appendicitis in children.

Authors:  O Obinwa; M Casidy; J Flynn
Journal:  Ir J Med Sci       Date:  2013-12-18       Impact factor: 1.568

8.  Diagnosis and management of acute appendicitis. EAES consensus development conference 2015.

Authors:  Ramon R Gorter; Hasan H Eker; Marguerite A W Gorter-Stam; Gabor S A Abis; Amish Acharya; Marjolein Ankersmit; Stavros A Antoniou; Simone Arolfo; Benjamin Babic; Luigi Boni; Marlieke Bruntink; Dieuwertje A van Dam; Barbara Defoort; Charlotte L Deijen; F Borja DeLacy; Peter Mnyh Go; Annelieke M K Harmsen; Rick S van den Helder; Florin Iordache; Johannes C F Ket; Filip E Muysoms; M Mahir Ozmen; Michail Papoulas; Michael Rhodes; Jennifer Straatman; Mark Tenhagen; Victor Turrado; Andras Vereczkei; Ramon Vilallonga; Jort D Deelder; Jaap Bonjer
Journal:  Surg Endosc       Date:  2016-09-22       Impact factor: 4.584

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.